QQ客服 官方微博 反馈留言

	Risk-Adapted Survival Benefit of Intensity-Modulated Radiation Therapy in Early-Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: A Multicenter Study
	Wu, T.; Yang, Y.; Zhu, S. Y.; Shi, M.; Su, H.; Wang, Y.; He, X.; Li-ming, X.; Yuan, Z. Y.; Zhang, L. L.
	2018
卷号	102期号:3页码:E358-E359
ISSN号	0360-3016
DOI	10.1016/j.ijrobp.2018.07.1081
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6351700
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Wu, T.,Yang, Y.,Zhu, S. Y.,et al. Risk-Adapted Survival Benefit of Intensity-Modulated Radiation Therapy in Early-Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: A Multicenter Study[J],2018,102(3):E358-E359.
APA	Wu, T..,Yang, Y..,Zhu, S. Y..,Shi, M..,Su, H..,...&Li, Y. X..(2018).Risk-Adapted Survival Benefit of Intensity-Modulated Radiation Therapy in Early-Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: A Multicenter Study.,102(3),E358-E359.
MLA	Wu, T.,et al."Risk-Adapted Survival Benefit of Intensity-Modulated Radiation Therapy in Early-Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: A Multicenter Study".102.3(2018):E358-E359.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。